nonhodgkin lymphoma

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical, Laboratory and Epidemiologic Characterization of

Recruiting
  • Waldenstrom Macroglobulinemia
  • +4 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Metastatic Cancer, Solid Tumor, Advanced Cancer Trial in Korea, Republic of, United States (Evorpacept (ALX148), Pembrolizumab,

    Active, not recruiting
    • Metastatic Cancer
    • +3 more
    • Evorpacept (ALX148)
    • +5 more
    • Denver, Colorado
    • +9 more
    Jul 20, 2022

    NonHodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Lymphoma Trial in Houston (EBVST Cells, Nivolumab)

    Completed
    • NonHodgkin Lymphoma
    • +6 more
    • EBVST Cells
    • Nivolumab
    • Houston, Texas
    • +1 more
    Jul 19, 2021

    Multiple Myeloma, NonHodgkin Lymphoma Trial in United States (TAS4464)

    Terminated
    • Multiple Myeloma
    • NonHodgkin Lymphoma
    • Bethesda, Maryland
    • +6 more
    Jun 18, 2021

    Cancer Diagnosis and Treatment on Everyday Life

    Active, not recruiting
    • Breast Cancer Female
    • +17 more
      • Aberystwyth, United Kingdom
      • +110 more
      Mar 16, 2021

      NonHodgkin Lymphoma Trial in Mumbai (Standard Arm, Experimental Arm)

      Recruiting
      • NonHodgkin Lymphoma
      • Standard Arm
      • Experimental Arm
      • Mumbai, Maharashtra, India
        Tata Memorial Center
      Feb 20, 2017